Fingerprint
Dive into the research topics of 'Phase II evaluation of the AMAP, 773U82 mesylate, in pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II evaluation of the AMAP, 773U82 mesylate, in pancreatic cancer
Donald L. Trump, James A. Hathorn, Louise B. Grochow, David Spriggs, Melody L. Eble, John A. Hohneker
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations